Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Bergheimer Str. 20, D-69115 Heidelberg, Germany.
J Natl Cancer Inst. 2010 Jan 20;102(2):89-95. doi: 10.1093/jnci/djp436. Epub 2009 Dec 30.
Colonoscopy is used for early detection and prevention of colorectal cancer, but evidence on the magnitude of overall protection and protection according to anatomical site through colonoscopy performed in the community setting is sparse. We assessed whether receiving a colonoscopy in the preceding 10-year period, compared with no colonoscopy, was associated with prevalence of advanced colorectal neoplasms (defined as cancers or advanced adenomas) at various anatomical sites.
A statewide cross-sectional study was conducted among 3287 participants in screening colonoscopy between May 1, 2005, and December 31, 2007, from the state of Saarland in Germany who were aged 55 years or older. Prevalence of advanced colorectal neoplasms was ascertained by screening colonoscopy and histopathologic examination of any polyps excised. Previous colonoscopy history was obtained by standardized questionnaire, and its association with prevalence of advanced colorectal neoplasms was estimated, after adjustment for potential confounding factors by log-binomial regression.
Advanced colorectal neoplasms were detected in 308 (11.4%) of the 2701 participants with no previous colonoscopy compared with 36 (6.1%) of the 586 participants who had undergone colonoscopy within the preceding 10 years. After adjustment, overall and site-specific adjusted prevalence ratios for previous colonoscopy in the previous 10-year period were as follows: overall, 0.52 (95% confidence interval [CI] = 0.37 to 0.73); cecum and ascending colon, 0.99 (95% CI = 0.50 to 1.97); hepatic flexure and transverse colon, 1.21 (95% CI = 0.60 to 2.42); right-sided colon combined (cecum to transverse colon), 1.05 (95% CI = 0.63 to 1.76); splenic flexure and descending colon, 0.36 (95% CI = 0.16 to 0.82); sigmoid colon, 0.29 (95% CI = 0.16 to 0.53); rectum, 0.07 (95% CI = 0.02 to 0.40); left colon and rectum combined (splenic flexure to rectum, referred to as left-sided elsewhere), 0.33 (95% CI = 0.21 to 0.53).
Prevalence of left-sided advanced colorectal neoplasms, but not right-sided advanced neoplasms, was strongly reduced within a 10-year period after colonoscopy, even in the community setting.
结肠镜检查用于早期发现和预防结直肠癌,但关于在社区环境中进行结肠镜检查的总体保护程度以及根据解剖部位的保护程度的证据很少。我们评估了在过去 10 年内接受结肠镜检查与未接受结肠镜检查相比,与各种解剖部位的晚期结直肠肿瘤(定义为癌症或高级腺瘤)的患病率之间的关系。
在德国萨尔州,对 2005 年 5 月 1 日至 2007 年 12 月 31 日期间接受筛查性结肠镜检查的 3287 名 55 岁或以上的参与者进行了一项全州性的横断面研究。通过筛查性结肠镜检查和切除的任何息肉的组织病理学检查确定晚期结直肠肿瘤的患病率。通过标准化问卷获得既往结肠镜检查史,并通过对数二项式回归调整潜在混杂因素后,估计其与晚期结直肠肿瘤患病率之间的关系。
在 2701 名无既往结肠镜检查史的参与者中,有 308 名(11.4%)检测到晚期结直肠肿瘤,而在过去 10 年内接受过结肠镜检查的 586 名参与者中,有 36 名(6.1%)检测到晚期结直肠肿瘤。调整后,过去 10 年内进行结肠镜检查的总体和部位特异性调整后的患病率比分别为:总体,0.52(95%置信区间[CI] = 0.37 至 0.73);盲肠和升结肠,0.99(95%CI = 0.50 至 1.97);肝曲和横结肠,1.21(95%CI = 0.60 至 2.42);右半结肠合并(盲肠至横结肠),1.05(95%CI = 0.63 至 1.76);脾曲和降结肠,0.36(95%CI = 0.16 至 0.82);乙状结肠,0.29(95%CI = 0.16 至 0.53);直肠,0.07(95%CI = 0.02 至 0.40);左半结肠和直肠合并(脾曲至直肠,称为左半结肠),0.33(95%CI = 0.21 至 0.53)。
即使在社区环境中,结肠镜检查后 10 年内,左半结肠晚期结直肠肿瘤的患病率(而非右半结肠)明显降低。